During her two decades at The New England Journal of Medicine , Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of what the pharmaceutical industry has become–and argues for essential, long-overdue change.
Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth and power to push their agenda through Congress, the FDA, and academic medical centers.
Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective.
The American pharmaceutical industry needs to be saved, mainly from itself, and Dr. Angell proposes a program of vital reforms, which includes restoring impartiality to clinical research and severing the ties between drug companies and medical education. Written with fierce passion and substantiated with in-depth research, The Truth About the Drug Companies is a searing indictment of an industry that has spun out of control.
From the Hardcover edition.
發表於2024-12-23
The Truth About the Drug Companies 2024 pdf epub mobi 電子書 下載
圖書標籤: 製藥 healthcare Pharmaceutical 醫藥 行業 英文原版 美國 經濟,政治和曆史
3 aspects: dubious R&D; excessive marketing (to doctors and patients); political clout in execution and legislation branches of government
評分作者寫得挺客觀,可惜我看到已經是齣版十年之後,真希望能有新作。
評分作者在The New England Journal of Medicine(美國學術權威最強醫學期刊)工作瞭二十年的行業資深人士 雖然是十五年前寫的 現在的套路其實沒什麼變化 大藥企還是通過從學校科研機構license要不就是收購小藥廠獲得創新血液 而in-house齣來的科研成果少之又少 這種方法造就瞭大批富豪教授和醫生 學校教授手裏一般都有一個到幾個的公司 藥廠實際做的事跟開窯子沒任何區彆 自己隻是占瞭個有硬件有資本的優勢 入住以後招攬客人搞定治安的事窯子包瞭 招募來漂亮小姑娘接客然後自己拿大頭 還得各種忽悠政府 說‘我們這是為瞭社會穩定啊,我們這是解決就業啊‘ 畢竟做藥是商務活動 追求的就是利益最大化 不能用道德去約束 但是當婊子還立牌坊就是太不要臉瞭
評分作者在The New England Journal of Medicine(美國學術權威最強醫學期刊)工作瞭二十年的行業資深人士 雖然是十五年前寫的 現在的套路其實沒什麼變化 大藥企還是通過從學校科研機構license要不就是收購小藥廠獲得創新血液 而in-house齣來的科研成果少之又少 這種方法造就瞭大批富豪教授和醫生 學校教授手裏一般都有一個到幾個的公司 藥廠實際做的事跟開窯子沒任何區彆 自己隻是占瞭個有硬件有資本的優勢 入住以後招攬客人搞定治安的事窯子包瞭 招募來漂亮小姑娘接客然後自己拿大頭 還得各種忽悠政府 說‘我們這是為瞭社會穩定啊,我們這是解決就業啊‘ 畢竟做藥是商務活動 追求的就是利益最大化 不能用道德去約束 但是當婊子還立牌坊就是太不要臉瞭
評分醫藥業存在著些骯髒的小秘密,他們不該用病人來達到這個目的。
The Truth About the Drug Companies 2024 pdf epub mobi 電子書 下載